Literature DB >> 22564924

Current UK management of locally recurrent rectal cancer.

D P Harji1, B Griffiths, D R McArthur, P M Sagar.   

Abstract

AIM: The study aimed to determine current UK practice in the management of locally recurrent rectal cancer (LRRC).
METHOD: An electronic based survey was sent to UK based Association of Coloproctology of Great Britain and Ireland members to establish current management in this patient group. A total of 188 questionnaires were sent out to consultant surgeons in a total of 105 colorectal units.
RESULTS: Seventy-nine consultants from 69 units responded, giving an overall response rate from consultants of 42% and from colorectal units of 66%. In all, 688 patients were managed by multidisciplinary teams in the 12 months prior to the survey. Seventy-four (94% of responders) surgeons had experience of operating on patients with LRRC. Fifty-nine (74.6%) operated on one to three per year and four (5%) operated on more than 10 patients per year. Central and anterior recurrences were most commonly undertaken locally, with most complex recurrences being referred to a tertiary centre. Forty-seven (61%) surgeons worked to an algorithm.
CONCLUSION: A small number of specialist units in the UK manage the full spectrum of LRRC but the majority of patients are managed in small volume centres. The survey provides a snapshot of current activity in the UK and may provide a stimulus for discussion about how to expand and improve the care of a technically challenging group of patients.
© 2012 The Authors. Colorectal Disease © 2012 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2012        PMID: 22564924     DOI: 10.1111/j.1463-1318.2012.03070.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  4 in total

1.  Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.

Authors:  F Selvaggi; C Fucini; G Pellino; G Sciaudone; I Maretto; I Mondi; N Bartolini; F Caminati; S Pucciarelli
Journal:  Tech Coloproctol       Date:  2014-11-11       Impact factor: 3.781

2.  Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.

Authors:  A M Mehta; G Hellawell; D Burling; S Littler; A Antoniou; J T Jenkins
Journal:  Tech Coloproctol       Date:  2018-10-10       Impact factor: 3.781

3.  Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Evaghelos Xynos; Paris Tekkis; Nikolaos Gouvas; Louiza Vini; Evangelia Chrysou; Maria Tzardi; Vassilis Vassiliou; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Christos Dervenis; Christos Emmanouilidis; Panagiotis Georgiou; Ourania Katopodi; Panteleimon Kountourakis; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Charina Triantopoulou; Spyridon Xynogalos; Niki Karachaliou; Nikolaos Ziras; Odysseas Zoras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun

4.  Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.

Authors:  Quentin Denost; Florence Saillour; Lindy Masya; Helene Maillou Martinaud; Stephanie Guillon; Marion Kret; Eric Rullier; Bruno Quintard; Michael Solomon
Journal:  BMC Cancer       Date:  2016-04-04       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.